{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:13:48Z","timestamp":1793740428897,"version":"4.6.1"},"reference-count":55,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/or.2015.4089","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T08:14:57Z","timestamp":1435306497000},"page":"1185-1192","source":"Crossref","is-referenced-by-count":24,"title":["Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells"],"prefix":"10.3892","volume":"34","author":[{"given":"NAOKI","family":"MAKITA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ITASU","family":"NINOMIYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMOYA","family":"TSUKADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHI","family":"OKAMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHINICHI","family":"HARADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHINICHI","family":"NAKANUMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEISHO","family":"SAKAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ISAMU","family":"MAKINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUN","family":"KINOSHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIRONORI","family":"HAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATSUNOBU","family":"OYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HISATOSHI","family":"NAKAGAWARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TOMOHARU","family":"MIYASHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEHIRO","family":"TAJIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"TAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SACHIO","family":"FUSHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSUO","family":"OHTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"key":"key20180107211854_b1-or-34-03-1185","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"key20180107211854_b2-or-34-03-1185","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1200\/JCO.1999.17.9.2915","article-title":"Definitive chemoradiotherapy for T4 and\/or M1 lymph node squamous cell carcinoma of the esophagus","volume":"17","author":"Ohtsu","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180107211854_b3-or-34-03-1185","first-page":"252","article-title":"A pilot study of chemoradiotherapy with weekly docetaxel for thoracic esophageal carcinoma with T4 and\/or M1 lymph node metastasis","volume":"2","author":"Makino","year":"2011","journal-title":"World J Oncol"},{"key":"key20180107211854_b4-or-34-03-1185","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180107211854_b5-or-34-03-1185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.bjc.6600684","article-title":"Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus","volume":"88","author":"Kaneko","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107211854_b6-or-34-03-1185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jjco\/hyh107","article-title":"Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: A Japan Esophageal Oncology Group (JEOG)\/Japan Clinical Oncology Group trial (JCOG9516)","volume":"34","author":"Ishida","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107211854_b7-or-34-03-1185","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01)","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"key":"key20180107211854_b8-or-34-03-1185","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107211854_b9-or-34-03-1185","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","article-title":"Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II\u2013III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)","volume":"81","author":"Kato","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107211854_b10-or-34-03-1185","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/j.1460-2075.1996.tb00608.x","article-title":"Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro","volume":"15","author":"Vettese-Dadey","year":"1996","journal-title":"EMBO J"},{"key":"key20180107211854_b11-or-34-03-1185","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1093\/emboj\/16.8.2096","article-title":"Histone acetylation: Influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression","volume":"16","author":"Ura","year":"1997","journal-title":"EMBO J"},{"key":"key20180107211854_b12-or-34-03-1185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4161\/cc.3.6.927","article-title":"Histonedeacetylase inhibitors for the treatment of cancer","volume":"3","author":"Lindemann","year":"2004","journal-title":"Cell Cycle"},{"key":"key20180107211854_b13-or-34-03-1185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"key20180107211854_b14-or-34-03-1185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/0008-5472.CAN-03-2630","article-title":"Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275","volume":"64","author":"Camphausen","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107211854_b15-or-34-03-1185","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1158\/1078-0432.CCR-04-0537","article-title":"Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation","volume":"10","author":"Camphausen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107211854_b16-or-34-03-1185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1667\/RR3192","article-title":"Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors","volume":"161","author":"Zhang","year":"2004","journal-title":"Radiat Res"},{"key":"key20180107211854_b17-or-34-03-1185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2004.12.088","article-title":"Modulation of radiation response by histone deacetylase inhibition","volume":"62","author":"Chinnaiyan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180107211854_b18-or-34-03-1185","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20774","article-title":"Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid","volume":"114","author":"Camphausen","year":"2005","journal-title":"Int J Cancer"},{"key":"key20180107211854_b19-or-34-03-1185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4161\/cbt.4.7.1922","article-title":"The histone deacetylase inhibitor, trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X","volume":"4","author":"Karagiannis","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"key20180107211854_b20-or-34-03-1185","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/1078-0432.CCR-04-2088","article-title":"Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity","volume":"11","author":"Munshi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107211854_b21-or-34-03-1185","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1667\/RR3345","article-title":"Novel HDAC inhibitors with radiosensitizing properties","volume":"163","author":"Jung","year":"2005","journal-title":"Radiat Res"},{"key":"key20180107211854_b22-or-34-03-1185","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/cbr.2009.0629","article-title":"HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells","volume":"24","author":"Chen","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"key20180107211854_b23-or-34-03-1185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12032-010-9559-3","article-title":"Enhanced radiosensitivity of EC109 cells by inhibition of HDAC1 expression","volume":"29","author":"Zhang","year":"2012","journal-title":"Med Oncol"},{"key":"key20180107211854_b24-or-34-03-1185","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1038\/sj.onc.1210174","article-title":"Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments","volume":"26","author":"Karagiannis","year":"2007","journal-title":"Oncogene"},{"key":"key20180107211854_b25-or-34-03-1185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1042\/BJ20080413","article-title":"Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining","volume":"417","author":"Mahaney","year":"2009","journal-title":"Biochem J"},{"key":"key20180107211854_b26-or-34-03-1185","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.dnarep.2010.09.019","article-title":"A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation","volume":"9","author":"Dobbs","year":"2010","journal-title":"DNA Repair"},{"key":"key20180107211854_b27-or-34-03-1185","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1078-0432.CCR-11-0767","article-title":"Molecular pathways: Old drugs define new pathways: Non-histone acetylation at the crossroads of the DNA damage response and autophagy","volume":"18","author":"Botrugno","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107211854_b28-or-34-03-1185","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","article-title":"Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis","volume":"13","author":"Cohen","year":"2004","journal-title":"Mol Cell"},{"key":"key20180107211854_b29-or-34-03-1185","doi-asserted-by":"crossref","first-page":"e94213","DOI":"10.1371\/journal.pone.0094213","article-title":"Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: Involvement of Ku70\/SirT-1 in thermo-protection","volume":"9","author":"Hassan","year":"2014","journal-title":"PLoS One"},{"key":"key20180107211854_b30-or-34-03-1185","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1158\/0008-5472.CAN-06-3996","article-title":"Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107211854_b31-or-34-03-1185","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107211854_b32-or-34-03-1185","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180107211854_b33-or-34-03-1185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/epi.1.3.2896","article-title":"The epigenetic modifier, valproic acid, enhances radiation sensitivity","volume":"1","author":"Karagiannis","year":"2006","journal-title":"Epigenetics"},{"key":"key20180107211854_b34-or-34-03-1185","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1158\/1078-0432.CCR-08-0643","article-title":"Postradiation sensitization of the histone deacetylase inhibitor valproic acid","volume":"14","author":"Chinnaiyan","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107211854_b35-or-34-03-1185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-10-0471","article-title":"Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis","volume":"9","author":"Chen","year":"2011","journal-title":"Mol Cancer Res"},{"key":"key20180107211854_b36-or-34-03-1185","first-page":"2140","article-title":"Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma","volume":"40","author":"Shoji","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107211854_b37-or-34-03-1185","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.1073\/pnas.0707828104","article-title":"HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination","volume":"104","author":"Adimoolam","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211854_b38-or-34-03-1185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1269\/jrr.10033","article-title":"Early increase of radiation-induced \u03b3H2AX foci in a human Ku70\/80 knockdown cell line characterized by an enhanced radiosensitivity","volume":"51","author":"Vandersickel","year":"2010","journal-title":"J Radiat Res"},{"key":"key20180107211854_b39-or-34-03-1185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2041-9414-2-3","article-title":"Evaluation of the efficacy of radiation-modifying compounds using \u03b3H2AX as a molecular marker of DNA double-strand breaks","volume":"2","author":"Mah","year":"2011","journal-title":"Genome Integr"},{"key":"key20180107211854_b40-or-34-03-1185","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J Biol Chem"},{"key":"key20180107211854_b41-or-34-03-1185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","article-title":"Histone deacetylases and cancer","volume":"6","author":"Barneda-Zahonero","year":"2012","journal-title":"Mol Oncol"},{"key":"key20180107211854_b42-or-34-03-1185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00280-008-0747-1","article-title":"Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas","volume":"63","author":"Erlich","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107211854_b43-or-34-03-1185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hematol Oncol"},{"key":"key20180107211854_b44-or-34-03-1185","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107211854_b45-or-34-03-1185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"key20180107211854_b46-or-34-03-1185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11060-008-9662-x","article-title":"Valproic acid was well tolerated in heavily pretreated pediatric patients with high-grade glioma","volume":"90","author":"Wolff","year":"2008","journal-title":"J Neurooncol"},{"key":"key20180107211854_b47-or-34-03-1185","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1074\/jbc.270.30.17923","article-title":"Modulation of chromatin folding by histone acetylation","volume":"270","author":"Garcia-Ramirez","year":"1995","journal-title":"J Biol Chem"},{"key":"key20180107211854_b48-or-34-03-1185","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107211854_b49-or-34-03-1185","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4161\/cc.7.4.5405","article-title":"Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments","volume":"7","author":"Harikrishnan","year":"2008","journal-title":"Cell Cycle"},{"key":"key20180107211854_b50-or-34-03-1185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4161\/cc.5.3.2421","article-title":"The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation","volume":"5","author":"Karagiannis","year":"2006","journal-title":"Cell Cycle"},{"key":"key20180107211854_b51-or-34-03-1185","doi-asserted-by":"crossref","first-page":"20436","DOI":"10.1074\/jbc.M000202200","article-title":"Histone deacetylases specifically down-regulate p53-dependent gene activation","volume":"275","author":"Juan","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107211854_b52-or-34-03-1185","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature07312","article-title":"Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing","volume":"455","author":"Mimitou","year":"2008","journal-title":"Nature"},{"key":"key20180107211854_b53-or-34-03-1185","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1126\/science.1192049","article-title":"Human SIRT6 promotes DNA end resection through CtIP deacetylation","volume":"329","author":"Kaidi","year":"2010","journal-title":"Science"},{"key":"key20180107211854_b54-or-34-03-1185","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1158\/0008-5472.CAN-11-3172","article-title":"Acetylation: A novel link between double-strand break repair and autophagy","volume":"72","author":"Shubassi","year":"2012","journal-title":"Cancer Res"},{"key":"key20180107211854_b55-or-34-03-1185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1269\/jrr.08036","article-title":"Role of DNA double-strand break repair genes in cell proliferation under low dose-rate irradiation conditions","volume":"49","author":"Tomita","year":"2008","journal-title":"J Radiat Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4089\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T15:01:22Z","timestamp":1566918082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,6,26]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/or.2015.4089"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4089","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}